Paradigm4 logo — The Right Cohorts built from all your multimodal data. Human...

Paradigm4

The Right Cohorts built from all your multimodal data. Human-in-the-loop ML validation.

Founded 2010 United States Waltham, United States 28 employees Series A Analytics, Big Data +2

General Information

Company Name Paradigm4
Founded Year 2010
Location United States Waltham, United States
Employees 28
Industries Analytics, Big Data, Biotechnology +1
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Paradigm4. To contact Paradigm4, visit paradigm4.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Paradigm4

Paradigm4 is a biotechnology startup based in the United States that offers the REVEAL analytical solutions platform to expedite the discovery of druggable targets. Founded in 2009, the company has garnered validation from global pharmas and biotechs, with testimonials attesting to the platform's ability to uncover crucial insights. The last significant investment, a Series A round, took place on 30 November 2015, with participation from Golden Seeds, Kepha Partners, and Sigma Prime Ventures. With its expertise in Analytics, Big Data, and Biotechnology, Paradigm4 remains dedicated to accelerating target discovery in the pharmaceutical sector. Embracing the slogan "The Right Druggable Targets. Fast.," the company continues to gain recognition within the industry. For further information, one can visit their website at paradigm4.com or connect with them on Twitter at @paradigm4 and on LinkedIn at company/paradigm4.

Taxonomy: druggable targets, analytical solutions, target discovery, genomic data, clinical data, big data, life sciences data management, elastic computing, scalable analytics, bioinformatics services, scientific data support

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 3
Golden Seeds, Kepha Partners +1
30 Nov 2015
Seed Round Undisclosed 1
Kepha Partners
15 Dec 2011

Paradigm4 Alternatives & Competitors

View All Alternatives
Paradigm4 vs
Bainom
Bainom United States

Unlocking clinical insights by decoding intricate multi-omic patterns.

Pre-Seed
2 employees
AI, Analytics
Paradigm4 vs
ONTOFORCE
ONTOFORCE Belgium

Through our data and technology solutions, we transform data into actionable insights, and streamlin...

Series A
36 employees
Analytics, Biotechnology
Paradigm4 vs
Sentieon
Sentieon United States

Sentieon's software dramatically improves the performance of bioinformatics tools. Our mission is to...

Series B
11 employees
Biotechnology, Clean Energy

FAQ About Paradigm4

The Right Cohorts built from all your multimodal data. Human-in-the-loop ML validation.
Paradigm4 was founded in 2010.
Paradigm4 is headquartered in Waltham, United States.
Paradigm4 operates in Analytics, Big Data, Biotechnology and Clean Energy. Its work centres on druggable targets, analytical solutions, target discovery and genomic data.
Paradigm4 has approximately 28 employees.
Paradigm4 has completed 2 funding rounds. The latest funding stage is Series A.
Top alternatives and competitors to Paradigm4 include Bainom, ONTOFORCE, Sentieon, BenevolentAI, MavenView. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Paradigm4 and Bainom are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Paradigm4, https://bouncewatch.com/company/paradigm4, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes